EUS-B-FNA for left adrenal gland analysis in lung cancer patients.

Completed

• Conditions: lung cancer; 10029107

• Registration Number: NL-OMON42163
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 40

Inclusion Criteria

lung cancer
suspected left adrenal gland on imaging

Exclusion Criteria

contraindication for EUS/EUS-B

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The proportion of patients with a successful EUS-B-FNA procedure for LAG<br /><br>analysis. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Sensitivity EUS-B-FNA and EUS-FNA for LAG metastases.</p><br>